MDINDL,MDSTDT,DCMNAME,PT,MDEDDT,REPEATSN,MDONG,STUDY,CPEVENT,MDQSN2,MDIND,MDQSN1,VISIT,SUBEVE,INVSITE,MDVERB,MDQSNL2,MDQSNL1,MDPNT,MDSTT,MDAT4T,MDAT3T,MDAT2T,MDAT1T
METASTATIC DISEASE,2005,MD_CANCER_MEDS,01-04,2006,2,N,MAXIS-08,BASELINE,PD,M,H,1,0,C008_408,ANASTRAZOLE,PROGRESSIVE DISEASE,HORMONE THERAPY,,,,,,
METASTATIC DISEASE,20090217,MD_CANCER_MEDS,01-09,20090317,6,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,IRIHOTECAN,PROGRESSIVE DISEASE,CHEMOTHERAPY,,,,,,
METASTATIC DISEASE,200506,MD_CANCER_MEDS,01-06,200510,6,N,MAXIS-08,BASELINE,PD,M,H,1,0,C008_408,LUPROLIDE,PROGRESSIVE DISEASE,HORMONE THERAPY,,,,,,
METASTATIC DISEASE,200602,MD_CANCER_MEDS,01-06,200606,3,N,MAXIS-08,BASELINE,PD,M,H,1,1,C008_408,LUPROLIDE,PROGRESSIVE DISEASE,HORMONE THERAPY,,,,,,
LOCALLY ADVANCED,20060719,MD_CANCER_MEDS,01-07,20060719,4,N,MAXIS-08,BASELINE,PD,L,O,1,0,C008_408,RIGHT AND LEFT HEPATIC LOBE RADIO FREQUENCY ABLATION,PROGRESSIVE DISEASE,OTHER,,,,,,
METASTATIC DISEASE,200806,MD_CANCER_MEDS,01-06,200807,1,N,MAXIS-08,BASELINE,PD,M,C,1,3,C008_408,TEMOZOLAMIDE,PROGRESSIVE DISEASE,CHEMOTHERAPY,,,,,,
LOCALLY ADVANCED,20060412,MD_CANCER_MEDS,01-07,20060530,3,N,MAXIS-08,BASELINE,PD,L,O,1,0,C008_408,UNKNOWN DRUG TRANSARTERIAL CHEMO EMBOLIZATION X2,PROGRESSIVE DISEASE,OTHER,,,,,,
METASTATIC DISEASE,2004,MD_CANCER_MEDS,01-11,200503,3,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,VINORELBIN,STABLE DISEASE,CHEMOTHERAPY,,,,,,
METASTATIC DISEASE,20070927,MD_CANCER_MEDS,01-05,20071120,2,N,MAXIS-08,BASELINE,PD,M,O,1,0,C008_408,YTTRIUM 90,PROGRESSIVE DISEASE,OTHER,,,,,,
METASTATIC DISEASE,200808,MD_CANCER_MEDS,01-06,200809,3,N,MAXIS-08,BASELINE,PD,M,C,1,3,C008_408,AZACYTIDINE,PROGRESSIVE DISEASE,CHEMOTHERAPY,AZACITIDINE,,,,,
METASTATIC DISEASE,20081002,MD_CANCER_MEDS,01-09,20090317,3,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,AVASTIN,STABLE DISEASE,CHEMOTHERAPY,BEVACIZUMAB,AVASTIN                            /01555201/,"MONOCLONAL ANTIBODIES, L01XC","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200605,MD_CANCER_MEDS,01-04,200608,4,N,MAXIS-08,BASELINE,,M,C,1,0,C008_408,BEVACIZUMAB,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),CHEMOTHERAPY,BEVACIZUMAB,,"MONOCLONAL ANTIBODIES, L01XC","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200708,MD_CANCER_MEDS,01-10,200903,6,N,MAXIS-08,BASELINE,PR,M,C,1,1,C008_408,BEVACIZUMAB,PARTIAL RESPONSE,CHEMOTHERAPY,BEVACIZUMAB,,"MONOCLONAL ANTIBODIES, L01XC","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,200608,MD_CANCER_MEDS,01-14,200611,4,N,MAXIS-08,BASELINE,PD,L,C,1,0,C008_408,BEVACIZUMAB,PROGRESSIVE DISEASE,CHEMOTHERAPY,BEVACIZUMAB,,"MONOCLONAL ANTIBODIES, L01XC","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200506,MD_CANCER_MEDS,01-06,200510,1,N,MAXIS-08,BASELINE,PD,M,H,1,1,C008_408,BICALUTAMIDE,PROGRESSIVE DISEASE,HORMONE THERAPY,BICALUTAMIDE,,"ANTI-ANDROGENS, L02BB","HORMONE ANTAGONISTS AND RELATED AGENTS, L02B","ENDOCRINE THERAPY, L02","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200602,MD_CANCER_MEDS,01-06,200606,4,N,MAXIS-08,BASELINE,PD,M,H,1,1,C008_408,BICALUTAMIDE,PROGRESSIVE DISEASE,HORMONE THERAPY,BICALUTAMIDE,,"ANTI-ANDROGENS, L02BB","HORMONE ANTAGONISTS AND RELATED AGENTS, L02B","ENDOCRINE THERAPY, L02","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200610,MD_CANCER_MEDS,01-04,200705,1,N,MAXIS-08,BASELINE,SD,M,C,1,1,C008_408,CAPECITABINE,STABLE DISEASE,CHEMOTHERAPY,CAPECITABINE,,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200511,MD_CANCER_MEDS,01-06,200602,2,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,CAPECITABINE,PROGRESSIVE DISEASE,CHEMOTHERAPY,CAPECITABINE,,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200304,MD_CANCER_MEDS,01-10,200310,4,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,CAPECITABINE,STABLE DISEASE,CHEMOTHERAPY,CAPECITABINE,,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200410,MD_CANCER_MEDS,01-10,200606,6,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,CAPECITABINE,STABLE DISEASE,CHEMOTHERAPY,CAPECITABINE,,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200810,MD_CANCER_MEDS,01-10,200903,1,N,MAXIS-08,BASELINE,SD,M,C,1,2,C008_408,CAPECITABINE,STABLE DISEASE,CHEMOTHERAPY,CAPECITABINE,,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200612,MD_CANCER_MEDS,01-13,200705,5,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,CAPECITABINE,PROGRESSIVE DISEASE,CHEMOTHERAPY,CAPECITABINE,,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20041202,MD_CANCER_MEDS,01-16,20050420,4,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,CAPECITABINE,STABLE DISEASE,CHEMOTHERAPY,CAPECITABINE,,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20071001,MD_CANCER_MEDS,01-12,20080123,5,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,XELODA,PROGRESSIVE DISEASE,CHEMOTHERAPY,CAPECITABINE,XELODA,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080123,MD_CANCER_MEDS,01-12,20080318,2,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,XELODA,PROGRESSIVE DISEASE,CHEMOTHERAPY,CAPECITABINE,XELODA,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20090319,MD_CANCER_MEDS,01-12,200904,5,N,MAXIS-08,BASELINE,SD,M,C,1,2,C008_408,XELODA,STABLE DISEASE,CHEMOTHERAPY,CAPECITABINE,XELODA,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200710,MD_CANCER_MEDS,01-06,20080430,5,N,MAXIS-08,BASELINE,PD,M,C,1,2,C008_408,CARBOPLATIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,CARBOPLATIN,,"PLATINUM COMPOUNDS, L01XA","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200810,MD_CANCER_MEDS,01-06,200902,6,N,MAXIS-08,BASELINE,PD,M,C,1,3,C008_408,CARBOPLATIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,CARBOPLATIN,,"PLATINUM COMPOUNDS, L01XA","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200410,MD_CANCER_MEDS,01-10,200606,2,N,MAXIS-08,BASELINE,SD,M,C,1,1,C008_408,CETUXIMAB,STABLE DISEASE,CHEMOTHERAPY,CETUXIMAB,,"MONOCLONAL ANTIBODIES, L01XC","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,200903,MD_CANCER_MEDS,01-14,200905,6,N,MAXIS-08,BASELINE,PD,L,C,1,0,C008_408,CETUXIMAB,PROGRESSIVE DISEASE,CHEMOTHERAPY,CETUXIMAB,,"MONOCLONAL ANTIBODIES, L01XC","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200807,MD_CANCER_MEDS,01-15,20100208,1,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,CETUXIMAB,STABLE DISEASE,CHEMOTHERAPY,CETUXIMAB,,"MONOCLONAL ANTIBODIES, L01XC","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,200805,MD_CANCER_MEDS,01-01,20080714,2,N,MAXIS-08,BASELINE,PD,L,C,1,0,C008_408,CISPLATIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,CISPLATIN,,"PLATINUM COMPOUNDS, L01XA","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20090203,MD_CANCER_MEDS,01-09,20090317,1,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,CISPLATIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,CISPLATIN,,"PLATINUM COMPOUNDS, L01XA","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200807,MD_CANCER_MEDS,01-15,20100208,3,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,CISPLATIN,STABLE DISEASE,CHEMOTHERAPY,CISPLATIN,,"PLATINUM COMPOUNDS, L01XA","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200810,MD_CANCER_MEDS,01-03,200811,1,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,AVASTIN + IXEMPRA,PROGRESSIVE DISEASE,CHEMOTHERAPY,COMBINATIONS OF ANTINEOPLASTIC AGENTS,,"COMBINATIONS OF ANTINEOPLASTIC AGENTS, L01XY","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200807,MD_CANCER_MEDS,01-03,200809,2,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,AVASTIN + XELODA,PROGRESSIVE DISEASE,CHEMOTHERAPY,COMBINATIONS OF ANTINEOPLASTIC AGENTS,,"COMBINATIONS OF ANTINEOPLASTIC AGENTS, L01XY","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200707,MD_CANCER_MEDS,01-13,2007,1,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,"CYTOXAN, METHOTREXATE, FLUOROURACIL",PROGRESSIVE DISEASE,CHEMOTHERAPY,COMBINATIONS OF ANTINEOPLASTIC AGENTS,,"COMBINATIONS OF ANTINEOPLASTIC AGENTS, L01XY","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20010424,MD_CANCER_MEDS,01-16,200106,3,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,"CYTOXAN, METHOTREXATE, FLUOROURACIL",PROGRESSIVE DISEASE,CHEMOTHERAPY,COMBINATIONS OF ANTINEOPLASTIC AGENTS,,"COMBINATIONS OF ANTINEOPLASTIC AGENTS, L01XY","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200705,MD_CANCER_MEDS,01-04,200712,2,N,MAXIS-08,BASELINE,SD,M,C,1,1,C008_408,CYTOXAN/ADRIAMYCIN,STABLE DISEASE,CHEMOTHERAPY,COMBINATIONS OF ANTINEOPLASTIC AGENTS,,"COMBINATIONS OF ANTINEOPLASTIC AGENTS, L01XY","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20091027,MD_CANCER_MEDS,01-16,20091215,1,N,MAXIS-08,BASELINE,SD,M,C,1,1,C008_408,GEMCITABINE/CARBOPLATIN,STABLE DISEASE,CHEMOTHERAPY,COMBINATIONS OF ANTINEOPLASTIC AGENTS,,COMBINATIONS OF ANTINEOPLASTIC AGENTS,"OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080521,MD_CANCER_MEDS,01-09,20080703,1,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,GEMZAR/TARCEVA,PROGRESSIVE DISEASE,CHEMOTHERAPY,COMBINATIONS OF ANTINEOPLASTIC AGENTS,,COMBINATIONS OF ANTINEOPLASTIC AGENTS,"OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
ADJUVANT,19980128,MD_CANCER_MEDS,01-16,19980428,1,N,MAXIS-08,BASELINE,,A,C,1,0,C008_408,DOXORUBICIN/CYCLOPHOSPHAMIDE,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),CHEMOTHERAPY,CYCLOPHOSPHAMID W/DOXORUBICIN,DOXORUBICIN W/CYCLOPHOSPHAMIDE,,"CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
ADJUVANT,200308,MD_CANCER_MEDS,01-06,200403,2,N,MAXIS-08,BASELINE,,A,C,1,0,C008_408,CYCLOPHOSPHAMIDE,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),CHEMOTHERAPY,CYCLOPHOSPHAMIDE,,"NITROGEN MUSTARD ANALOGUES, L01AA","ALKYLATING AGENTS, L01A","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200709,MD_CANCER_MEDS,01-06,20080430,2,N,MAXIS-08,BASELINE,SD,M,C,1,2,C008_408,CYCLOPHOSPHAMIDE,STABLE DISEASE,CHEMOTHERAPY,CYCLOPHOSPHAMIDE,,"NITROGEN MUSTARD ANALOGUES, L01AA","ALKYLATING AGENTS, L01A","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,200702,MD_CANCER_MEDS,01-03,200709,1,N,MAXIS-08,BASELINE,PD,L,C,1,0,C008_408,CYTOXAN,PROGRESSIVE DISEASE,CHEMOTHERAPY,CYCLOPHOSPHAMIDE,CYTOXAN,"NITROGEN MUSTARD ANALOGUES, L01AA","ALKYLATING AGENTS, L01A","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20070323,MD_CANCER_MEDS,01-03,200706,4,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,CYTOXAN,PROGRESSIVE DISEASE,CHEMOTHERAPY,CYCLOPHOSPHAMIDE,CYTOXAN,"NITROGEN MUSTARD ANALOGUES, L01AA","ALKYLATING AGENTS, L01A","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080123,MD_CANCER_MEDS,01-12,20080519,6,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,CYTOXAN,PROGRESSIVE DISEASE,CHEMOTHERAPY,CYCLOPHOSPHAMIDE,CYTOXAN,"NITROGEN MUSTARD ANALOGUES, L01AA","ALKYLATING AGENTS, L01A","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20090319,MD_CANCER_MEDS,01-12,200904,1,N,MAXIS-08,BASELINE,SD,M,C,1,2,C008_408,CYTOXAN,STABLE DISEASE,CHEMOTHERAPY,CYCLOPHOSPHAMIDE,CYTOXAN,"NITROGEN MUSTARD ANALOGUES, L01AA","ALKYLATING AGENTS, L01A","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,200702,MD_CANCER_MEDS,01-03,200709,3,N,MAXIS-08,BASELINE,PD,L,C,1,0,C008_408,DOCETAXEL,PROGRESSIVE DISEASE,CHEMOTHERAPY,DOCETAXEL,,"TAXANES, L01CD","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200605,MD_CANCER_MEDS,01-04,200608,3,N,MAXIS-08,BASELINE,,M,C,1,0,C008_408,DOCETAXEL,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),CHEMOTHERAPY,DOCETAXEL,,"TAXANES, L01CD","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200712,MD_CANCER_MEDS,01-04,200803,3,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,DOCETAXEL,PROGRESSIVE DISEASE,CHEMOTHERAPY,DOCETAXEL,,"TAXANES, L01CD","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,200702,MD_CANCER_MEDS,01-03,200709,2,N,MAXIS-08,BASELINE,PD,L,C,1,0,C008_408,ADRIAMYCIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,DOXORUBICIN,ADRIAMYCIN                         /00330901/,"ANTHRACYCLINES AND RELATED SUBSTANCES, L01DB","CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20070323,MD_CANCER_MEDS,01-03,200705,5,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,ADRIAMYCIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,DOXORUBICIN,ADRIAMYCIN                         /00330901/,"ANTHRACYCLINES AND RELATED SUBSTANCES, L01DB","CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,20080609,MD_CANCER_MEDS,01-07,20080609,2,N,MAXIS-08,BASELINE,PD,L,O,1,0,C008_408,ADRIAMYCIN TRANSARTERIAL CHEMO EMBOLIZATION,PROGRESSIVE DISEASE,OTHER,DOXORUBICIN,ADRIAMYCIN                         /00330901/,"ANTHRACYCLINES AND RELATED SUBSTANCES, L01DB","CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
ADJUVANT,200308,MD_CANCER_MEDS,01-06,200403,1,N,MAXIS-08,BASELINE,,A,C,1,0,C008_408,DOXORUBICIN,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),CHEMOTHERAPY,DOXORUBICIN,,"ANTHRACYCLINES AND RELATED SUBSTANCES, L01DB","CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080318,MD_CANCER_MEDS,01-12,20080519,3,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,DOXORUBICIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,DOXORUBICIN,,"ANTHRACYCLINES AND RELATED SUBSTANCES, L01DB","CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20081029,MD_CANCER_MEDS,01-12,20090304,6,N,MAXIS-08,BASELINE,SD,M,C,1,1,C008_408,DOXORUBICIN,STABLE DISEASE,CHEMOTHERAPY,DOXORUBICIN,,"ANTHRACYCLINES AND RELATED SUBSTANCES, L01DB","CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200712,MD_CANCER_MEDS,01-13,200812,4,N,MAXIS-08,BASELINE,SD,M,C,1,1,C008_408,DOXORUBICIN,STABLE DISEASE,CHEMOTHERAPY,DOXORUBICIN,,"ANTHRACYCLINES AND RELATED SUBSTANCES, L01DB","CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200812,MD_CANCER_MEDS,01-06,200902,1,N,MAXIS-08,BASELINE,PD,M,C,1,4,C008_408,DOXIL,PROGRESSIVE DISEASE,CHEMOTHERAPY,DOXORUBICIN HYDROCHLORIDE,DOXIL                              /00330902/,"ANTHRACYCLINES AND RELATED SUBSTANCES, L01DB","CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20100126,MD_CANCER_MEDS,01-16,20100323,2,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,DOXORUBICIN HCL,PROGRESSIVE DISEASE,CHEMOTHERAPY,DOXORUBICIN HYDROCHLORIDE,,"ANTHRACYCLINES AND RELATED SUBSTANCES, L01DB","CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080508,MD_CANCER_MEDS,01-02,20081030,2,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,TARCEVA,PROGRESSIVE DISEASE,CHEMOTHERAPY,ERLOTINIB,,"PROTEIN KINASE INHIBITORS, L01XE","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
ADJUVANT,200404,MD_CANCER_MEDS,01-06,200410,4,N,MAXIS-08,BASELINE,,A,C,1,0,C008_408,ETOPOSIDE,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),CHEMOTHERAPY,ETOPOSIDE,,"PODOPHYLLOTOXIN DERIVATIVES, L01CB","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200709,MD_CANCER_MEDS,01-06,20080430,3,N,MAXIS-08,BASELINE,SD,M,C,1,2,C008_408,ETOPOSIDE,STABLE DISEASE,CHEMOTHERAPY,ETOPOSIDE,,"PODOPHYLLOTOXIN DERIVATIVES, L01CB","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200701,MD_CANCER_MEDS,01-10,200708,3,N,MAXIS-08,BASELINE,SD,M,C,1,1,C008_408,FLUORODEOXYURIDINE,STABLE DISEASE,CHEMOTHERAPY,FLUOROURACIL,,"PYRIMIDINE ANALOGUES, L01BC","PYRIMIDINE ANALOGUES, L01BC","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20070322,MD_CANCER_MEDS,01-08,20070927,1,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,FLUOROURACIL,STABLE DISEASE,CHEMOTHERAPY,FLUOROURACIL,,"PYRIMIDINE ANALOGUES, L01BC","PYRIMIDINE ANALOGUES, L01BC","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20090324,MD_CANCER_MEDS,01-08,20090407,4,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,FLUOROURACIL,PROGRESSIVE DISEASE,CHEMOTHERAPY,FLUOROURACIL,,"PYRIMIDINE ANALOGUES, L01BC","PYRIMIDINE ANALOGUES, L01BC","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080715,MD_CANCER_MEDS,01-09,20090317,2,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,FLUOROURACIL,STABLE DISEASE,CHEMOTHERAPY,FLUOROURACIL,,"PYRIMIDINE ANALOGUES, L01BC","PYRIMIDINE ANALOGUES, L01BC","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20001130,MD_CANCER_MEDS,01-10,200102,2,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,FLUOROURACIL,PROGRESSIVE DISEASE,CHEMOTHERAPY,FLUOROURACIL,,"PYRIMIDINE ANALOGUES, L01BC","PYRIMIDINE ANALOGUES, L01BC","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200708,MD_CANCER_MEDS,01-10,200810,5,N,MAXIS-08,BASELINE,PR,M,C,1,1,C008_408,FLUOROURACIL,PARTIAL RESPONSE,CHEMOTHERAPY,FLUOROURACIL,,"PYRIMIDINE ANALOGUES, L01BC","PYRIMIDINE ANALOGUES, L01BC","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,200606,MD_CANCER_MEDS,01-14,200712,2,N,MAXIS-08,BASELINE,SD,L,C,1,0,C008_408,FLUOROURACIL,STABLE DISEASE,CHEMOTHERAPY,FLUOROURACIL,,"PYRIMIDINE ANALOGUES, L01BC","PYRIMIDINE ANALOGUES, L01BC","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200902,MD_CANCER_MEDS,01-06,200905,5,N,MAXIS-08,BASELINE,PD,M,C,1,4,C008_408,LEUCOVORIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,FOLINIC ACID,LEUCOVORIN                         /00566701/,"DETOXIFYING AGENTS FOR ANTINEOPLASTIC TREATMENT, V03AF","ALL OTHER THERAPEUTIC PRODUCTS, V03A","ALL OTHER THERAPEUTIC PRODUCTS, V03","VARIOUS, V"
METASTATIC DISEASE,20070322,MD_CANCER_MEDS,01-08,20070927,2,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,LEUCOVORIN,STABLE DISEASE,CHEMOTHERAPY,FOLINIC ACID,LEUCOVORIN                         /00566701/,"DETOXIFYING AGENTS FOR ANTINEOPLASTIC TREATMENT, V03AF","ALL OTHER THERAPEUTIC PRODUCTS, V03A","ALL OTHER THERAPEUTIC PRODUCTS, V03","VARIOUS, V"
METASTATIC DISEASE,20090324,MD_CANCER_MEDS,01-08,20090407,5,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,LEUCOVORIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,FOLINIC ACID,LEUCOVORIN                         /00566701/,"DETOXIFYING AGENTS FOR ANTINEOPLASTIC TREATMENT, V03AF","ALL OTHER THERAPEUTIC PRODUCTS, V03A","ALL OTHER THERAPEUTIC PRODUCTS, V03","VARIOUS, V"
METASTATIC DISEASE,20080715,MD_CANCER_MEDS,01-09,20090317,5,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,LEUCOVORIN,STABLE DISEASE,CHEMOTHERAPY,FOLINIC ACID,LEUCOVORIN                         /00566701/,"DETOXIFYING AGENTS FOR ANTINEOPLASTIC TREATMENT, V03AF","ALL OTHER THERAPEUTIC PRODUCTS, V03A","ALL OTHER THERAPEUTIC PRODUCTS, V03","VARIOUS, V"
METASTATIC DISEASE,20001130,MD_CANCER_MEDS,01-10,200102,3,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,LEUCOVORIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,FOLINIC ACID,LEUCOVORIN                         /00566701/,"DETOXIFYING AGENTS FOR ANTINEOPLASTIC TREATMENT, V03AF","ALL OTHER THERAPEUTIC PRODUCTS, V03A","ALL OTHER THERAPEUTIC PRODUCTS, V03","VARIOUS, V"
METASTATIC DISEASE,200410,MD_CANCER_MEDS,01-10,200606,1,N,MAXIS-08,BASELINE,SD,M,C,1,1,C008_408,LEUCOVORIN,STABLE DISEASE,CHEMOTHERAPY,FOLINIC ACID,LEUCOVORIN                         /00566701/,"DETOXIFYING AGENTS FOR ANTINEOPLASTIC TREATMENT, V03AF","ALL OTHER THERAPEUTIC PRODUCTS, V03A","ALL OTHER THERAPEUTIC PRODUCTS, V03","VARIOUS, V"
METASTATIC DISEASE,20071001,MD_CANCER_MEDS,01-12,200801,4,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,LEUCOVORIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,FOLINIC ACID,LEUCOVORIN                         /00566701/,"DETOXIFYING AGENTS FOR ANTINEOPLASTIC TREATMENT, V03AF","ALL OTHER THERAPEUTIC PRODUCTS, V03A","ALL OTHER THERAPEUTIC PRODUCTS, V03","VARIOUS, V"
LOCALLY ADVANCED,200606,MD_CANCER_MEDS,01-14,200712,1,N,MAXIS-08,BASELINE,SD,L,C,1,0,C008_408,LEUCOVORIN,STABLE DISEASE,CHEMOTHERAPY,FOLINIC ACID,LEUCOVORIN                         /00566701/,"DETOXIFYING AGENTS FOR ANTINEOPLASTIC TREATMENT, V03AF","ALL OTHER THERAPEUTIC PRODUCTS, V03A","ALL OTHER THERAPEUTIC PRODUCTS, V03","VARIOUS, V"
METASTATIC DISEASE,200603,MD_CANCER_MEDS,01-13,200612,4,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,FULVESTRANT,STABLE DISEASE,CHEMOTHERAPY,FULVESTRANT,,"ANTI-ESTROGENS, L02BA","HORMONE ANTAGONISTS AND RELATED AGENTS, L02B","ENDOCRINE THERAPY, L02","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080829,MD_CANCER_MEDS,01-08,20090212,3,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,GEMCITABINE,STABLE DISEASE,CHEMOTHERAPY,GEMCITABINE,,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,2004,MD_CANCER_MEDS,01-11,200503,4,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,GEMCITABINE,STABLE DISEASE,CHEMOTHERAPY,GEMCITABINE,,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,2007,MD_CANCER_MEDS,01-13,2007,2,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,GEMCITABINE,PROGRESSIVE DISEASE,CHEMOTHERAPY,GEMCITABINE,,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080520,MD_CANCER_MEDS,01-16,20080603,5,N,MAXIS-08,BASELINE,,M,C,1,0,C008_408,GEMCITABINE,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),CHEMOTHERAPY,GEMCITABINE,,"PYRIMIDINE ANALOGUES, L01BC","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
ADJUVANT,200404,MD_CANCER_MEDS,01-06,200410,5,N,MAXIS-08,BASELINE,,A,C,1,0,C008_408,IFOSFAMIDE,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),CHEMOTHERAPY,IFOSFAMIDE,,"NITROGEN MUSTARD ANALOGUES, L01AA","ALKYLATING AGENTS, L01A","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
ADJUVANT,1998,MD_CANCER_MEDS,01-11,1998,1,N,MAXIS-08,BASELINE,,A,I,1,0,C008_408,INTERFERON,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),IMMUNOTHERAPY,INTERFERON,,"INTERFERONS, L03AB","IMMUNOSTIMULANTS, L03A","IMMUNOSTIMULANTS, L03","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,2004,MD_CANCER_MEDS,01-11,200503,2,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,INTERLEUKIN 2,STABLE DISEASE,CHEMOTHERAPY,INTERLEUKIN-2,,"INTERLEUKINS, L03AC","IMMUNOSTIMULANTS, L03A","IMMUNOSTIMULANTS, L03","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,200805,MD_CANCER_MEDS,01-01,20080714,1,N,MAXIS-08,BASELINE,PD,L,C,1,0,C008_408,IRINOTECAN,PROGRESSIVE DISEASE,CHEMOTHERAPY,IRINOTECAN,,"OTHER ANTINEOPLASTIC AGENTS, L01X","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200608,MD_CANCER_MEDS,01-06,200608,6,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,IRINOTECAN,PROGRESSIVE DISEASE,CHEMOTHERAPY,IRINOTECAN,,"OTHER ANTINEOPLASTIC AGENTS, L01X","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200806,MD_CANCER_MEDS,01-06,200807,2,N,MAXIS-08,BASELINE,PD,M,C,1,3,C008_408,IRINOTECAN,PROGRESSIVE DISEASE,CHEMOTHERAPY,IRINOTECAN,,"OTHER ANTINEOPLASTIC AGENTS, L01X","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20001130,MD_CANCER_MEDS,01-10,200102,1,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,IRINOTECAN,PROGRESSIVE DISEASE,CHEMOTHERAPY,IRINOTECAN,,"OTHER ANTINEOPLASTIC AGENTS, L01X","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200708,MD_CANCER_MEDS,01-10,200903,4,N,MAXIS-08,BASELINE,PR,M,C,1,1,C008_408,IRINOTECAN,PARTIAL RESPONSE,CHEMOTHERAPY,IRINOTECAN,,"OTHER ANTINEOPLASTIC AGENTS, L01X","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,200611,MD_CANCER_MEDS,01-14,200712,5,N,MAXIS-08,BASELINE,SD,L,C,1,0,C008_408,IRINOTECAN,STABLE DISEASE,CHEMOTHERAPY,IRINOTECAN,,"OTHER ANTINEOPLASTIC AGENTS, L01X","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,200903,MD_CANCER_MEDS,01-14,200905,1,N,MAXIS-08,BASELINE,PD,L,C,1,1,C008_408,IRINOTECAN,PROGRESSIVE DISEASE,CHEMOTHERAPY,IRINOTECAN,,"OTHER ANTINEOPLASTIC AGENTS, L01X","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20090605,MD_CANCER_MEDS,01-13,20090727,6,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,IXABEPILONE,PROGRESSIVE DISEASE,CHEMOTHERAPY,IXABEPILONE,,"OTHER CYTOTOXIC ANTIBIOTICS, L01DC","CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
ADJUVANT,200412,MD_CANCER_MEDS,01-12,20080123,2,N,MAXIS-08,BASELINE,,A,C,1,0,C008_408,LETROZOLE,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),CHEMOTHERAPY,LETROZOLE,,"ENZYME INHIBITORS, L02BG","HORMONE ANTAGONISTS AND RELATED AGENTS, L02B","ENDOCRINE THERAPY, L02","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200506,MD_CANCER_MEDS,01-13,200603,3,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,LETROZOLE,STABLE DISEASE,CHEMOTHERAPY,LETROZOLE,,"ENZYME INHIBITORS, L02BG","HORMONE ANTAGONISTS AND RELATED AGENTS, L02B","ENDOCRINE THERAPY, L02","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,2005,MD_CANCER_MEDS,01-04,2005,5,N,MAXIS-08,BASELINE,PD,M,H,1,1,C008_408,LUPRON,PROGRESSIVE DISEASE,HORMONE THERAPY,LEUPRORELIN ACETATE,LUPRON,"GONADOTROPIN RELEASING HORMONE ANALOGUES, L02AE","HORMONES AND RELATED AGENTS, L02A","ENDOCRINE THERAPY, L02","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200902,MD_CANCER_MEDS,01-06,200905,4,N,MAXIS-08,BASELINE,PD,M,C,1,4,C008_408,METHOTREXATE,PROGRESSIVE DISEASE,CHEMOTHERAPY,METHOTREXATE,,"OTHER IMMUNOSUPPRESSANTS, L04AX","IMMUNOSUPPRESSANTS, L04A","IMMUNOSUPPRESSANTS, L04","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080123,MD_CANCER_MEDS,01-12,20080318,1,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,METHOTREXATE,PROGRESSIVE DISEASE,CHEMOTHERAPY,METHOTREXATE,,"OTHER IMMUNOSUPPRESSANTS, L04AX","IMMUNOSUPPRESSANTS, L04A","IMMUNOSUPPRESSANTS, L04","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20090319,MD_CANCER_MEDS,01-12,200904,2,N,MAXIS-08,BASELINE,SD,M,C,1,2,C008_408,METHOTREXATE,STABLE DISEASE,CHEMOTHERAPY,METHOTREXATE,,"OTHER IMMUNOSUPPRESSANTS, L04AX","IMMUNOSUPPRESSANTS, L04A","IMMUNOSUPPRESSANTS, L04","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200710,MD_CANCER_MEDS,01-06,20080430,4,N,MAXIS-08,BASELINE,PD,M,C,1,2,C008_408,MITOXANTRONE,PROGRESSIVE DISEASE,CHEMOTHERAPY,MITOXANTRONE,,"ANTHRACYCLINES AND RELATED SUBSTANCES, L01DB","CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES, L01D","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20090324,MD_CANCER_MEDS,01-08,20090407,6,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,OXALIPLATIN,PROGRESSIVE DISEASE,CHEMOTHERAPY,OXALIPLATIN,,"PLATINUM COMPOUNDS, L01XA","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080715,MD_CANCER_MEDS,01-09,20081223,4,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,OXALIPLATIN,STABLE DISEASE,CHEMOTHERAPY,OXALIPLATIN,,"PLATINUM COMPOUNDS, L01XA","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200410,MD_CANCER_MEDS,01-10,200606,5,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,OXALIPLATIN,STABLE DISEASE,CHEMOTHERAPY,OXALIPLATIN,,"PLATINUM COMPOUNDS, L01XA","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,200606,MD_CANCER_MEDS,01-14,200611,3,N,MAXIS-08,BASELINE,SD,L,C,1,0,C008_408,OXALIPLATIN,STABLE DISEASE,CHEMOTHERAPY,OXALIPLATIN,,"PLATINUM COMPOUNDS, L01XA","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080904,MD_CANCER_MEDS,01-12,20090304,5,N,MAXIS-08,BASELINE,SD,M,C,1,1,C008_408,ABRAXANE,STABLE DISEASE,CHEMOTHERAPY,PACLITAXEL,ABRAXANE,"TAXANES, L01CD","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080729,MD_CANCER_MEDS,01-16,20090922,6,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,ABRAXANE,STABLE DISEASE,CHEMOTHERAPY,PACLITAXEL,ABRAXANE,"TAXANES, L01CD","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200810,MD_CANCER_MEDS,01-06,200902,5,N,MAXIS-08,BASELINE,PD,M,C,1,3,C008_408,PACLITAXEL,PROGRESSIVE DISEASE,CHEMOTHERAPY,PACLITAXEL,,"TAXANES, L01CD","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080529,MD_CANCER_MEDS,01-12,20090304,4,N,MAXIS-08,BASELINE,PR,M,C,1,1,C008_408,PACLITAXEL,PARTIAL RESPONSE,CHEMOTHERAPY,PACLITAXEL,,"TAXANES, L01CD","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200502,MD_CANCER_MEDS,01-13,200506,2,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,PACLITAXEL,PROGRESSIVE DISEASE,CHEMOTHERAPY,PACLITAXEL,,"TAXANES, L01CD","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,2007,MD_CANCER_MEDS,01-13,200712,3,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,PACLITAXEL,PROGRESSIVE DISEASE,CHEMOTHERAPY,PACLITAXEL,,"TAXANES, L01CD","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
ADJUVANT,19980429,MD_CANCER_MEDS,01-16,19980701,2,N,MAXIS-08,BASELINE,,A,C,1,0,C008_408,PACLITAXEL,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),CHEMOTHERAPY,PACLITAXEL,,"TAXANES, L01CD","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20090423,MD_CANCER_MEDS,01-09,20090603,2,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,ALIMTA,PROGRESSIVE DISEASE,CHEMOTHERAPY,PEMETREXED,ALIMTA                             /01493901/,"FOLIC ACID ANALOGUES, L01BA","ANTIMETABOLITES, L01B","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20090319,MD_CANCER_MEDS,01-12,200904,4,N,MAXIS-08,BASELINE,PD,M,C,1,2,C008_408,PREDNISONE,PROGRESSIVE DISEASE,CHEMOTHERAPY,PREDNISONE,,"GLUCOCORTICOIDS, H02AB","CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN, H02A","CORTICOSTEROIDS FOR SYSTEMIC USE, H02","SYSTEMIC HORMONAL PREP.,EXCL.SEX HORM.AND INSULIN, H"
METASTATIC DISEASE,20070926,MD_CANCER_MEDS,01-02,20080619,1,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,SORAFENIB,PROGRESSIVE DISEASE,CHEMOTHERAPY,SORAFENIB,,"PROTEIN KINASE INHIBITORS, L01XE","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200812,MD_CANCER_MEDS,01-06,200902,2,N,MAXIS-08,BASELINE,PD,M,C,1,4,C008_408,SORAFENIB,PROGRESSIVE DISEASE,CHEMOTHERAPY,SORAFENIB,,"PROTEIN KINASE INHIBITORS, L01XE","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080117,MD_CANCER_MEDS,01-05,20090421,1,N,MAXIS-08,BASELINE,PR,M,C,1,0,C008_408,SOREFINIB,PARTIAL RESPONSE,CHEMOTHERAPY,SORAFENIB,,"PROTEIN KINASE INHIBITORS, L01XE","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
LOCALLY ADVANCED,20081104,MD_CANCER_MEDS,01-07,20090428,1,N,MAXIS-08,BASELINE,PD,L,C,1,0,C008_408,SOREFINIB,PROGRESSIVE DISEASE,CHEMOTHERAPY,SORAFENIB,,"PROTEIN KINASE INHIBITORS, L01XE","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20070721,MD_CANCER_MEDS,01-11,20080804,5,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,SOREFINIB,STABLE DISEASE,CHEMOTHERAPY,SORAFENIB,,"PROTEIN KINASE INHIBITORS, L01XE","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200704,MD_CANCER_MEDS,01-06,200709,1,N,MAXIS-08,BASELINE,PD,M,C,1,2,C008_408,SUNITINIB,PROGRESSIVE DISEASE,CHEMOTHERAPY,SUNITINIB,,"PROTEIN KINASE INHIBITORS, L01XE","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200501,MD_CANCER_MEDS,01-04,200512,1,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,TAMOXIFEN,STABLE DISEASE,CHEMOTHERAPY,TAMOXIFEN,,"ANTI-ESTROGENS, L02BA","HORMONE ANTAGONISTS AND RELATED AGENTS, L02B","ENDOCRINE THERAPY, L02","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,19991220,MD_CANCER_MEDS,01-12,200412,1,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,TAMOXIFEN,STABLE DISEASE,CHEMOTHERAPY,TAMOXIFEN,,"ANTI-ESTROGENS, L02BA","HORMONE ANTAGONISTS AND RELATED AGENTS, L02B","ENDOCRINE THERAPY, L02","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20090425,MD_CANCER_MEDS,01-12,20090805,6,N,MAXIS-08,BASELINE,PD,M,C,1,2,C008_408,TAMOXIFEN,PROGRESSIVE DISEASE,CHEMOTHERAPY,TAMOXIFEN,,"ANTI-ESTROGENS, L02BA","HORMONE ANTAGONISTS AND RELATED AGENTS, L02B","ENDOCRINE THERAPY, L02","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,1996,MD_CANCER_MEDS,01-13,2001,1,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,TAMOXIFEN,STABLE DISEASE,CHEMOTHERAPY,TAMOXIFEN,,"ANTI-ESTROGENS, L02BA","HORMONE ANTAGONISTS AND RELATED AGENTS, L02B","ENDOCRINE THERAPY, L02","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200812,MD_CANCER_MEDS,01-13,200903,5,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,TAMOXIFEN,PROGRESSIVE DISEASE,CHEMOTHERAPY,TAMOXIFEN,,"ANTI-ESTROGENS, L02BA","HORMONE ANTAGONISTS AND RELATED AGENTS, L02B","ENDOCRINE THERAPY, L02","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200608,MD_CANCER_MEDS,01-06,200608,5,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,TEMOZOLOMIDE,PROGRESSIVE DISEASE,CHEMOTHERAPY,TEMOZOLOMIDE,,"OTHER ALKYLATING AGENTS, L01AX","ALKYLATING AGENTS, L01A","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20081222,MD_CANCER_MEDS,01-11,20090223,6,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,TEMSIROLIMUS,PROGRESSIVE DISEASE,CHEMOTHERAPY,TEMSIROLIMUS,,"PROTEIN KINASE INHIBITORS, L01XE","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200710,MD_CANCER_MEDS,01-06,20080430,6,N,MAXIS-08,BASELINE,PD,M,C,1,2,C008_408,THIOTEPA,PROGRESSIVE DISEASE,CHEMOTHERAPY,THIOTEPA,,"ETHYLENE IMINES, L01AC","ALKYLATING AGENTS, L01A","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20071001,MD_CANCER_MEDS,01-12,20080123,3,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,VINBLASTINE,PROGRESSIVE DISEASE,CHEMOTHERAPY,VINBLASTINE,,"VINCA ALKALOIDS AND ANALOGUES, L01CA","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
ADJUVANT,200308,MD_CANCER_MEDS,01-06,200403,3,N,MAXIS-08,BASELINE,,A,C,1,0,C008_408,VINCRISTINE,NOT APPLICABLE(IF NEOADJUVANT OR ADJUVANT REGIMEN),CHEMOTHERAPY,VINCRISTINE,,"VINCA ALKALOIDS AND ANALOGUES, L01CA","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20090319,MD_CANCER_MEDS,01-12,200904,3,N,MAXIS-08,BASELINE,SD,M,C,1,2,C008_408,VINCRISTINE,STABLE DISEASE,CHEMOTHERAPY,VINCRISTINE,,"VINCA ALKALOIDS AND ANALOGUES, L01CA","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20050504,MD_CANCER_MEDS,01-16,20080415,3,N,MAXIS-08,BASELINE,SD,M,C,1,1,C008_408,NAVELBINE,STABLE DISEASE,CHEMOTHERAPY,VINORELBINE,NAVELBINE                          /00988501/,"VINCA ALKALOIDS AND ANALOGUES, L01CA","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AGENTS, L01"
METASTATIC DISEASE,200802,MD_CANCER_MEDS,01-03,200806,6,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,VINORELBINE,PROGRESSIVE DISEASE,CHEMOTHERAPY,VINORELBINE,,"VINCA ALKALOIDS AND ANALOGUES, L01CA","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,20080402,MD_CANCER_MEDS,01-04,20081217,4,N,MAXIS-08,BASELINE,PD,M,C,1,1,C008_408,VINORELBINE,PROGRESSIVE DISEASE,CHEMOTHERAPY,VINORELBINE,,"VINCA ALKALOIDS AND ANALOGUES, L01CA","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200902,MD_CANCER_MEDS,01-06,200905,3,N,MAXIS-08,BASELINE,PD,M,C,1,4,C008_408,VINORELBINE,PROGRESSIVE DISEASE,CHEMOTHERAPY,VINORELBINE,,"VINCA ALKALOIDS AND ANALOGUES, L01CA","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200705,MD_CANCER_MEDS,01-13,200707,6,N,MAXIS-08,BASELINE,PD,M,C,1,0,C008_408,VINORELBINE,PROGRESSIVE DISEASE,CHEMOTHERAPY,VINORELBINE,,"VINCA ALKALOIDS AND ANALOGUES, L01CA","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200807,MD_CANCER_MEDS,01-15,20100208,2,N,MAXIS-08,BASELINE,SD,M,C,1,0,C008_408,VINORELBINE,STABLE DISEASE,CHEMOTHERAPY,VINORELBINE,,"VINCA ALKALOIDS AND ANALOGUES, L01CA","PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, L01C","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
METASTATIC DISEASE,200808,MD_CANCER_MEDS,01-06,200809,4,N,MAXIS-08,BASELINE,PD,M,C,1,3,C008_408,VORINOSTAT,PROGRESSIVE DISEASE,CHEMOTHERAPY,VORINOSTAT,,"OTHER ANTINEOPLASTIC AGENTS, L01XX","OTHER ANTINEOPLASTIC AGENTS, L01X","ANTINEOPLASTIC AGENTS, L01","ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, L"
